Furthermore, we found that the effect of Cor in the treatment of NSCLC was mediated though reducing glutathione metabolism, activation of AMPK, and inhibition of AKT signaling pathways based on Pharma Mapper analysis of 241 potential protein targets for Cor. Here, AKT1 is linked to non-small cell lung carcinoma.